TwinBeech Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
TwinBeech Capital's EW Position: Q4 2025 in Review
TwinBeech Capital sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 56,905 shares — an estimated $4.43M sold.
TwinBeech Capital first reported a position in EW in Q4 2019 and held it in 13 quarters. The position peaked at $57.7M in Q3 2023. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.
- TwinBeech Capital reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
- TwinBeech Capital sold 56,905 Edwards Lifesciences shares in Q4 2025, an estimated $4.43M.
- TwinBeech Capital first reported a position in Edwards Lifesciences in Q4 2019 and held it in 13 quarters.
- TwinBeech Capital's Edwards Lifesciences position peaked at $57.7M in Q3 2023.
- 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.
Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.